Compass Therapeutics, Inc. (CMPX)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.94
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.00
P/B Ratio
1.94
Institutional Ownership
96.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 16.79M | $88.0M | 9.32% | -- | 2026-03-31 |
| ORBIMED ADVISORS LLC | 15.22M | $80.0M | 8.45% | -- | 2026-03-31 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 14.31M | $75.0M | 7.94% | +125.0K | 2026-03-31 |
| Vivo Capital, LLC | 9.55M | $50.0M | 5.30% | -- | 2026-03-31 |
| BlackRock, Inc. | 9.51M | $50.0M | 5.28% | +117.5K | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.49M | $44.0M | 4.71% | +4.05M | 2026-03-31 |
| ENAVATE SCIENCES GP, LLC | 7.79M | $41.0M | 4.32% | -- | 2026-03-31 |
| BVF INC/IL | 7.76M | $41.0M | 4.31% | -- | 2026-03-31 |
| STATE STREET CORP | 6.69M | $35.0M | 3.72% | +1.80M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.04M | $31.0M | 3.35% | -- | 2026-03-31 |